Saturday, October 20

Pfizer profits tumble on diabetes drug flop

Pfizer, the world’s largest drugmaker, was forced to take a $2.8bn writedown after scrapping its highly-touted inhaled insulin drug, Exubera.

Hmm, I am wondering if there is a better way to go about doing this entire medicine business? if a drug doesn't work, then it should be caught way way early, in any case, much before it hits this gobsmacking $2.8 billion level.

I am not an expert in pharmaceuticals but I do know manufacturing and banking. Where are the trip wires? how about distributed development?

How about creating an eco-system where patients, scientists, companies, testers, animals, software etc. etc. come together and have a rigorous way of winnowing out bad drugs quite early. But then again, never forget the propensity of large groups of people to make humdinger of mistakes!

Don't know, just idle rumination here!

Technorati Tags:

No comments: